GP-Act III Acquisition Corp. (GPAT)

NASDAQ: GPAT · USD

$11.1

+0.00 (0.0%)· Recorded snapshot

Market cap	179.4M
Net income (ttm)	8.4M
EPS (ttm)	$0.25
Shares out	16.2M
P/E (trailing)	43.7x
Beta	-0.00

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): 8.4M
EPS (ttm): $0.25
P/E (trailing): 43.7x
Market cap: 179.4M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ACGL	Arch Capital Group Ltd.	35B	8.8x	1.9x	15.9%	+15.1%	+24.9%	خرید قوی
AIG	American International Group Inc.	42.1B	12.8x	1.5x	7.9%	-10.3%	+4.5%	خرید قوی
AIZ	Assurant, Inc.	14.6B	13.7x	1.1x	14.3%	+6.5%	+41.9%	نگه‌داری

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-11-04 14:30 UTC

Forward P/En/a

P25 n/aP50 n/aP75 n/a

Trailing P/E43.7

P25 n/aP50 n/aP75 n/a

ROEn/a

P25 n/aP50 n/aP75 n/a

ROICn/a

P25 n/aP50 n/aP75 n/a

Benchmarks · 1M

All GPAT indicators

Market & fundamental data

Available fields

141

Groups with data

Currency

USD

Showing 141 of 141 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	USD
CIK code	0001834526
Company name	GP-Act III Acquisition Corp.
Country	United States
Country code	US
CUSIP number	G4035N103
Enterprise value	$180M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2020
Industry	Shell Companies
IPO date	2024-05-09
Is primary listing	Yes
Is SPAC	Yes
ISIN number	KYG4035N1034
Last 10-K release date	2026-03-26
Last refreshed	2026-11-04
Last stock split type	Never
Market cap	$179.4M
Market cap category	Micro-Cap
Options	No
Price	$11.10
Price currency	USD
Sector	Financials
SIC code	6770
Stock price date	2026-11-03
Symbol	GPAT
U.S. state	New York
Website	https://www.gp-act3.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (3Y)	39.44x
Earnings yield	2.29%
EV/Earnings	21.32x
FCF / EV yield	-0.23%
FCF yield	-0.23%
Industry P/E	98.81x
P/E ratio	43.73x
Sector forward P/E	13.72x
Sector P/E	15.79x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
ROA	-0.7%
ROCE	-2.34%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	-28.79%
EPS growth (Q)	-86.19%
EPS growth (QoQ)	-80.85%
Net income growth	-34.31%
Net income growth (Q)	-90.28%
Net income growth (QoQ)	-86.53%

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
EBIT	$-2.2M
EPS	$0.25
FCF per share	$-0.03
Financing cash flow	$-215.3M
Free cash flow	$-412,992
Investing cash flow	$215.4M
Net borrowing	$151,375
Net cash flow	$-235,728
Net income	$8.4M
Operating income	$-2.2M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Book value per share	$-1.01
Long-term assets	$98.2M
Long-term liabilities	$112.3M
Net cash (debt)	$-585,727
Net cash / market cap	-0.33%
Piotroski F-Score	1
Shareholders' equity	$-16.3M
Tangible book value	$-16.3M
Tangible book value per share	$-1.01
Total assets	$98.4M
Total cash	$10,586
Total debt	$596,313
Total liabilities	$114.7M
WACC	4.22%

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current assets	$119,565
Current liabilities	$2.4M
Current ratio	0.05
Net working capital	$-1.7M
Quick ratio	0
Working capital	$-2.3M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	7.76%
Dividend yield	0%
Shareholder yield	7.76%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	$10.83
1D price change	0%
1M price change	0.82%
1M total return	0.82%
1W price change	0.5%
1W total return	0.5%
1Y price change	4.11%
1Y return CAGR	4.11%
1Y total return	4.11%
20-day SMA	$11.04
200-day SMA	$10.77
3M price change	1.74%
3M total return	1.74%
50-day SMA	$10.97
50-day SMA vs 200-day SMA	50over200
52-week high	$12.00
52-week high date	2026-06-12
52-week low	$10.57
52-week low date	2025-11-11
6M price change	2.68%
6M total return	2.68%
All-time high	$12.00
All-time high date	2026-06-12
All-time low	$9.98
All-time low date	2024-07-01
Average true range (ATR)	$0.07
Average volume	12.2K
Beta (1Y)	0.11
Beta (2Y)	0.05
Beta (5Y)	-0
Change from 52-week high	-7.5%
Change from 52-week low	5.01%
Change from all-time high	-7.5%
Change from all-time low	11.22%
Monthly RSI	95.03
Open price	$0.00
Previous close	$0.00
Price vs 150-day SMA	2.48%
Price vs 20-day SMA	0.54%
Price vs 200-day SMA	3.05%
Price vs 50-day SMA	1.18%
Relative volume	0
Return from IPO price	11%
RSI	55.68
Sharpe ratio	0.54
Sortino ratio	1.8
Weekly RSI	72.58
YTD price change	3.84%
YTD total return	3.84%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	4.5M
Float percentage	27.84%
Shares change (QoQ)	-29.63%
Shares change (YoY)	-7.76%
Shares held by insiders	0.46%
Shares held by institutions	36.8%
Shares outstanding	16.2M
Short % of float	0.12%
Short % of shares	0.03%
Short ratio	1.1 days

Deeper analysis on GPAT

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this GPAT report

Is a complete GPAT research report available?

No complete published report is available for GP-Act III Acquisition Corp. (GPAT) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

GP-Act III Acquisition Corp. (GPAT)

Price

Financial snapshot

Fair-value bridge

Latest news · GPAT

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All GPAT indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on GPAT

Frequently asked questions